financetom
Business
financetom
/
Business
/
Tempus AI Partners With IFLI Over New Research Study on Follicular Lymphoma
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Tempus AI Partners With IFLI Over New Research Study on Follicular Lymphoma
Nov 14, 2025 6:51 AM

09:27 AM EST, 11/14/2025 (MT Newswires) -- Tempus AI ( TEM ) said Friday it is commencing a new follicular lymphoma research study in partnership with the Institute for Follicular Lymphoma Innovation.

The multi-year study will enroll participants to generate a multi-omic dataset to support research regarding precision medicine and biomarker discovery in follicular lymphoma, the company said.

Tempus' stock was down 4.7% in recent Friday premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved